Incubation with the mitochondria-targeted antioxidant, MitoQ10 significantly reduced AMPK activity in HSVECs from patients with CAD and T2D but not in cells from patients with CAD alone. This evidence concerns the gene PRKAA1 and type 2 diabetes mellitus.